The Leading Bioconjugate & Complex Biologics CDMO

Abzena serves as a fully integrated CDMO specializing in biologics as well as bioconjugates, Antibody-Drug Conjugates (ADCs), and linker-payload technologies. We offer comprehensive support for complex biologic drug candidates, encompassing the entire spectrum from initial discovery through developability assessment, lead selection and optimization, culminating in commercial-scale manufacturing.

Our robust scientific expertise, comprehensive intellectual property portfolio, and advanced facilities strategically located in the United Kingdom and the United States coalesce to equip clients with the necessary resources for implementing fully integrated drug development and manufacturing programs. Through collaborative engagement, Abzena leverages the extensive knowledge of our scientific team to determine the most efficacious development pathway tailored to each client's specific biologic needs.

Abzena's unwavering commitment to scientific progress translates into continuous advancements in technology, processes, and knowledge. Our agility and dedication empower us to streamline programs, minimize project risks, and ultimately contribute to the realization of groundbreaking therapeutic solutions.